Restricting conversations about voluntary assisted dying: implications for clinical practice

BMJ Supportive & Palliative Care
Lindy WillmottLuc Deliens

Abstract

On 19 June 2019, assisted dying became lawful in Victoria, the second most populous state in Australia. Section 8 of the Voluntary Assisted Dying Act is a legislative safeguard that is designed to ensure a patient's request for assistance to die is voluntary. This section prohibits health practitioners from initiating a conversation about assisted dying with the patient. This article explores the potential implications of this prohibition for effective communication between doctors and their patients, and the ability of doctors to provide high quality end-of-life (EOL) care in some cases. The authors reviewed and analysed literature on the importance of communication at the EOL including the need to understand and appropriately respond to Desire to Die or Desire to Hasten Death statements. A legal critique of section 8 of the Victorian Voluntary Assisted Dying Act was also undertaken to determine the scope of this new duty and how it aligns with existing legal obligations that would otherwise require doctors to provide information about EOL options requested by a patient. Contemporary literature suggests that open and honest communication between doctor and patient including the provision of information about all EOL options wh...Continue Reading

References

Aug 1, 1995·The American Journal of Psychiatry·H M ChochinovJ J Clinch
Mar 31, 2000·BMJ : British Medical Journal·G M LeydonK McPherson
Sep 9, 2000·Archives of Internal Medicine·K G WilsonD Curran
Sep 23, 2000·JAMA : the Journal of the American Medical Association·D G Larson, D R Tobin
Nov 14, 2000·JAMA : the Journal of the American Medical Association·K E SteinhauserJ A Tulsky
Jan 9, 2001·JAMA : the Journal of the American Medical Association·W BreitbartR Brescia
Mar 18, 2003·Journal of Critical Care·Daren K HeylandAmiram Gafni
Jun 7, 2005·Journal of the American Geriatrics Society·Gary S WinzelbergJames A Tulsky
Aug 30, 2005·Journal of Pain and Symptom Management·Josephine M ClaytonMartin H N Tattersall
Oct 13, 2005·Palliative Medicine·Sissel JohansenLars Johan Materstvedt
Jan 5, 2007·BMC Family Practice·Klaus EichlerJohann Steurer
Jul 28, 2007·Palliative Medicine·Colleen CartwrightGuido Miccinesi
Mar 13, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·David C CurrowAmy P Abernethy
Jul 5, 2008·Journal of Pain and Symptom Management·Richard HardingIrene J Higginson
Sep 18, 2010·BMJ : British Medical Journal·Stephen Barclay, Jane Maher
Apr 9, 2011·Patient Education and Counseling·Betty ChewningGregory Makoul
Apr 12, 2013·The New England Journal of Medicine·Elizabeth Trice LoggersF Marc Stewart
Jun 14, 2013·Palliative & Supportive Care·Behice Erci
Feb 20, 2014·International Journal of Epidemiology·Nicole SteckUNKNOWN Swiss National Cohort
Apr 26, 2014·Palliative & Supportive Care·Ernest GüellAntonio Pascual
Jul 1, 2015·Current Opinion in Supportive and Palliative Care·Miriam J Johnson, David C Currow
Mar 23, 2017·Journal of Medical Ethics·Mara Buchbinder
Feb 26, 2019·The Medical Journal of Australia·Ben P WhiteEliana Close
Apr 23, 2019·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Susan MacDonald

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.